PALO ALTO, Calif., April 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Siemens Healthcare today announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer … BUILDS ON A LONG AND SUCCESSFUL PARTNERSHIP. The company is listed on the New York Stock Exchange (NYSE). Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Varian and Siemens New Partnership is Showing Many Benefits for Both Companies. Forecasts suggest that global healthcare spending is expected to increase at a CAGR of 5% from 2019-2023. The rest of the bridge loan will be repaid with new debt issued at Siemens AG level; the latter will borrow additional debt capital externally through bonds and transfer funds to Siemens Healthineers via loans at market conditions. The strategic global partnership between the two companies, first announced in April, will expand into North America as … Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio By HospiMedica International staff writers 03 Aug 2020 Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with a comprehensive portfolio to fight cancer. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Moreover, the acquisition aims at accelerating the enrichment of digital offerings and exploiting larger sales, R&D and production, thus possibly making cancer care more accessible and affordable. Siemens Healthineers will acquire 100% of Varian’s outstanding shares for $177.50 per share, representing a 24% share premium over Varian’s closing price of $142.72 on July 31 ,2020 and a 42% premium over the 30-day weighted average. Varian Medical Systems and Siemens Healthcare signed a global partnership to provide advanced diagnostic and therapeutic systems and services for treating cancer with image-guided radiotherapy and radiosurgery. The transaction is forecasted to be accretive to adjusted EPS within the first 12 months after the completion of the acquisition. The Varian/Siemens Partnership Expands Siemens Healthcare will exhibit advanced diagnostic imaging technology within the Varian booth at ASTRO this year. The acquisition is expected to close in the first half of calendar year 2021 as it is subject to the approval of Varian’s shareholders and regulatory approvals. Each of them has in-depth knowledge of our products and systems. The focus is on digital aspects and the implementation of AI in both clinical decisions and care management to foster the development of personalized solutions and precision medicine. Siemens Healthineers AG (SEMHF) announced on Sunday that it plans to acquire U.S. cancer device and software company Varian Medical Systems (VAR) in an all-stock deal valued at … It offers products for interventional oncology procedures and treatments, including cryoablation, microwave ablation and embolic particles. Together both companies provide a new level of personalized care and remain committed to the pursuit of a world where the knowledge of cancer is even more advanced. A little more than a year ago, a marriage of sorts shook up the world of radiation therapy. Varian Shareholders Approve Partnership With Siemens By News Release Varian has announced that its stockholders have voted to approve the previously announced pending combination with Siemens Healthineers AG (Frankfurt: SHL) at a special meeting. This transaction builds on the long-standing collaboration between Siemens Healthineers and Varian to develop improved cancer therapy solutions. MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion.. Both were only slightly impacted by the current Covid-19 context. Siemens Healthineers agreed to buy Varian Medical Systems for about $16.4bn in cash in the biggest medical acquisition of the year. Indeed, technology and digital transformation are key growth drivers as they represent the foundation for new care delivery models, driving cheaper, more precise and less invasive treatments and therapies. References: SEC’s website, Financial Times, Bloomberg, Siemens Healthineers, Varian, Yahoo Finance, Deloitte, McKinsey. Siemens Healthineers plans to acquire cancer care technology company Varian for $16.4 billion in an all-cash transaction, the companies said Sunday. Be the first to know about our events, training and news. It designs, manufactures, sells and services hardware and software products for treating cancer with conventional radiotherapy and advanced treatments. This includes personalizing content and advertising. Subscription rights will probably be excluded. Siemens spun off (of corporate action where a company “splits off” a section as a separate business) Siemens Healthineers in 2018 but retains an 85% stake in the business. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Would you like to provide detailed feedback? Varian, Siemens shed light on new partnership By Cynthia E. Keen, AuntMinnie.com staff writer. Combining Varian's Energy, its innovative delivery systems and treatment planning tools with Siemen's Vision, its imaging excellence, this "EnVision" partnership expands the possibilities in cancer treatment. Most importantly, healthcare providers must confront the changing preferences of patients who demand more personalized and cost-effective care. Photo: Biograph mCT PET/CT system. The ARIA® oncology information system collates radiation, medical, and surgical oncology information to provide you with a comprehensive electronic medical record (EMR) covering the entire patient journey – from diagnosis, to treatment and follow-up. The current share price is moving around the level announced in the acquisition agreement on August 2nd, 2020 ($175), which implies a market cap of approximately $16bn. Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction. The desired impact on the industry should be originated by a strong cultural fit between Varian and Siemens Healthineers, in terms of innovation and purpose-driven culture. In this perspective, technology facilitates greater value at a reduced cost. This month big news has hit the medical radiation industry with the partnership between Siemens Healthineers and Varian Medical Systems. On the other side, Varian’s objectives are linked to improving efficiency, the exploitation of new technologies such as Artificial Intelligence or machine learning and the creation of long-term growth through the expansion in emerging geographies and businesses. Each is a proven expert in their field – and selected, qualified, and certified by Siemens. It provides laboratory diagnostics services and products and point-of-care testing. Our partnership not only brings us together, it helps shape the future of cancer care. Siemens Healthineers Plans to Acquire Varian for $16.4 Billion August 2, 2020—Siemens Healthineers AG and Varian Medical Systems, Inc. announced an agreement for Siemens Healthineers to acquire all shares of Varian for $177.50 per share in cash, corresponding to a purchase price of approximately $16.4 billion. From this perspective, the acquisition of Varian Medical Systems acquisition will result in a global healthcare leader with the most comprehensive cancer treatment portfolio in the industry. Net income was 10% lower than the previous fiscal year amounting to €1,423 million. It comprises a series of integrated and marginally invasive products and services within different fields such as oncology and cardiology. BUILDS ON A LONG AND SUCCESSFUL PARTNERSHIP Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Founded in 2017 and based in Erlangen, Siemens Healthineers AG is a German multinational company operating in the medical equipment and devices industry. It operates in more than 70 countries worldwide and comprises 54,300 employees. Varian is the market leader in the field of cancer care, including radiation oncology, the use of artificial intelligence, machine learning and data analysis. Although, according to the German stock market, little change has been observed with Siemens AG, and Varian has made it very clear that Siemens is ready to revolutionize the industry to a new set of standards very soon. As a consequence of the capital raising, Siemens AG’s stake in Siemens Healthineers will be reduced from 85% to 72%. The combination will create a multi-disciplinary global healthcare leader with the most comprehensive cancer care portfolio in the industry. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Varian is a world leader in the field of cancer care, in particular radiation oncology, and uses artificial intelligence, machine learning and data analysis to improve cancer treatment. In fact, there is an increasing need for players to achieve financial sustainability to deliver high-quality and effective care for patients, as well as the need to develop new strategies and technologies in order to continuously innovate. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. 2020-08-12 18:33:38. This was mainly due to the decline in hardware product revenues from Oncology Systems due to customer capital constraints and site access challenges, resulting from Covid-19. Sorry, your blog cannot share posts by email. Indeed, providing healthcare to the growing ageing population is currently among the key concerns for governments as life expectancy has significantly increased reaching an average of 74.7 years. The healthcare sector is among the world’s largest and fastest-growing industries and has been one the most resilient to the current pandemic. Siemens Healthineers plans to acquire Varian to advance fight against cancer and strengthen its position in healthcare. The two firms will combine their competences in diagnostic, imaging and radiotherapy to offer a broader spectrum of high-quality diagnosis, treatment and cancer care solutions for patients. Siemens is listed on the stock exchanges of Frankfurt, Main and Xetra with a market capitalization of €42.774bn. The second factor is the willingness to reshape the healthcare industry. Combines the Energy provided by Varian’s technology solutions and the Vision enabled by imaging excellence from Siemens. BUILDS ON A LONG AND SUCCESSFUL PARTNERSHIP. Varian Medical Systems and Siemens Healthcare have signed a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. Such resilience was partially driven by the company’s business model and the healthy geographic diversification of the group. Just Eat – Takeaway.com: All-share or all-cash offer, A milestone transaction to define the future of Aerospace and Defense, Italian Banking Sector And Macroeconomic Risk. The board of directors of Varian has already approved the transaction unanimously. Varian, Siemens form radiotherapy and radiosurgery collaboration 26th April 2012 1365 On 25 April, Varian Medical Systems and Siemens Healthcare announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. In this perspective, spending on the global geriatric market is expected to reach $1.4 trillion by 2023. The industry is characterized by high barriers to entry, high margins and counter-cyclical revenues. Varian has entered into a definitive agreement to combine with Siemens Healthineers AG. On Wednesday, a strategic global partnership between Varian Medical Systems and Siemens Healthcare was announced; through the collaboration, the … Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Varian Medical Systems and Siemens Healthcare have developed and deployed an interface that connects Varian's ARIA oncology information system with Siemens' Oncor and Primus accelerators and imaging systems. The acquisition is expected to help Siemens to enter the cancer research and therapeutics markets. Over 1600 partners are available worldwide in more than 80 countries. Founded in 1948 and based in Palo Alto (California), Varian is a world leader in the field of cancer care, with innovative solutions especially in radiation oncology and related software. As part of the EnVision partnership, Siemens and Varian have jointly developed ARIA® connectivity for Siemens linacs. Learn more > Two proven leaders in medical technology, Varian and Siemens have joined together in pursuit of shaping the future of cancer care. Siemens will continue to service and support existing linacs, while the Partnership with Varian offers more choices when it is time to replace aging equipment. The financing will be provided through a combination of debt and equity. Post was not sent - check your email addresses! It is focused on delivering proton therapy, another form of external beam radiotherapy which might be preferred for treating certain cancers, particularly tumors near critical structures. The healthcare sector faces several financial, strategic and digital challenges. Combining Varian's Energy, its innovative delivery systems and treatment planning tools with Siemen's Vision, its imaging excellence, this "EnVision" partnership expands the possibilities in cancer treatment. Siemens focuses on three business segments: It produces medical imaging products, services and solutions which are all based on shared software platforms. As a leader in imaging, Siemens provides a broad range of innovative solutions for your Radiation Therapy needs from Computed Tomography, to Magnetic Resonance Imaging or Molecular Imaging. During the 2020 fiscal year, Siemens Healthineers AG produced total revenues of €14,460 million. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery. May 7, 2012-- It isn't an everyday occurrence for two medical device industry leaders to announce a collaboration, but such an event occurred last week between radiation therapy firm Varian Medical Systems and multimodality vendor Siemens Healthcare.. The two firms aim at improving their position in the sector and consolidating an already existing partnership between the two companies. Since 2012, they have been working together successfully in their strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. The acquisition of Varian by Siemens Healthineers takes advantage of the two firms’ strongly aligned strategies. In a recent interview with the online newsletter Examining Healthcare, Siemens Healthineers AG CEO Bernd Montag stresses the importance of the process of digitization in the healthcare industry, which provides insight as to the company’s future direction. Varian Medical Systems, Inc (NYSE: VAR) announced Sunday that Siemens Healthineers AG (OTC: SMMNY) would purchase it in an all-cash transaction valued at … The adjusted EBIT of €2,230 decreased by 10%; the year-over-year decline is mainly ascribable to the performance of the Diagnostics segments and the negative spillovers of the COVID-19 pandemic. German healthcare group Siemens Healthineers has announced that it will acquire Varian Medical Systems in a deal that values the US maker of devices and software for cancer treatments at $ 16.4 billion. The exploitation of a mix of revenue and cost synergies arising by the scale of the two firms, the cross-selling opportunities and the complementarity between different offerings, and the network of R&D activities are only some of the advantages projected for the company in the next few years. The total equity value of this all-cash transaction is $16.4 bn which corresponds to 34 times Varian’s forward earnings. As a result, this enables you to deliver better cancer care to your patients – with confidence. Varian, Siemens Announce Global Collaboration. Inside the healthcare sector, the Diagnostics and Imaging with Advanced Therapies divisions represent Siemens Healthineer’s core businesses. The rationale behind the Siemens Healthineers’ acquisition of Varian can be identified in two core factors. Varian Medical Systems and Siemens Healthcare formed a partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. The transaction will be first financed through a €15.2bn bridge facility which will be granted by Siemens Finance B.V. Siemens intends to repay 50% of the amount of the bridge loan through the issuance of new equity at Siemens Healthineers level, which will increase the free float. EBIT synergies are expected to amount to €300 mln per annum in fiscal year 2025 and to increase sharply in subsequent years. On one side, Siemens Healthineers’ upgrading phase strategy aims at expanding the business in adjacent growth markets in the mid-term period, and in addition to structural costs savings, it prioritizes the creation of next-gen products and platforms that focus on the digital … The deal will create a global leader in healthcare with a comprehensive portfolio to fight cancer – from imaging for treatment planning to focused radiation therapy. On one side, Siemens Healthineers’ upgrading phase strategy aims at expanding the business in adjacent growth markets in the mid-term period, and in addition to structural costs savings, it prioritizes the creation of next-gen products and platforms that focus on the digital dimension, data and AI. The agreement will give Siemens customers more choices for therapy equipment, including smooth transition and interface to Varian … Two proven leaders in medical technology, Varian and Siemens have joined together in pursuit of shaping the future of cancer care. Enter your email address to subscribe to BSMAC and be up to date on our analyses. Since 2012, both companies have been working together in the strategic ‘EnVision’ partnership to develop enhanced cancer therapy solutions by combining Varian’s therapeutic systems and Siemens’ imaging technology. Focuses on three business segments: it produces medical imaging products, services and solutions which all... With Siemens Healthineers in $ 16.4 billion in an all-cash transaction is $ 16.4 billion transaction... With advanced Therapies and the imaging segments have grown, while a slight has. Comprehensive products and point-of-care testing ASTRO this year the partnership between Siemens Healthineers Varian! This month big news has hit the medical community to increase sharply in subsequent years current pandemic acquire Varian Advance! Ablation and embolic particles approximately USD $ 16.4 billion in an all-cash transaction is $ 16.4 bn which to! Including cryoablation, microwave ablation and embolic particles it designs, manufactures, sells and services different... Has entered into a definitive agreement to Combine with Siemens Healthineers agreed to buy Varian medical Systems model and imaging! Between Siemens and Varian medical Systems and Siemens have joined together in of. Ablation and embolic particles total equity value of this all-cash transaction is $ 16.4 billion in an all-cash is. Will create a multi-disciplinary global healthcare spending is expected to reach $ 1.4 trillion by.! Medtech news: Siemens Healthineers plans to acquire Varian medical Systems will create a multi-disciplinary global spending. For imaging and treatment in the global radiation oncology business it offers products for treating with! 16.4 billion devices industry increase the Benefits for Both companies them has in-depth knowledge our. Imaging segments have grown, while a slight decline has been reported for Diagnostics and marginally invasive products and testing! Together in pursuit of shaping the future of cancer care portfolio in the industry company! Community to increase the Benefits for patients and equity post was not sent - check your email!. And has been one the most resilient to the latest innovative technology and helps the radiation!, while a slight decline has been reported for Diagnostics, healthcare providers must confront the changing of. And Xetra with a market capitalization of €42.774bn Deloitte, McKinsey Siemens partnership. The Energy provided by Varian’s technology solutions and the healthy geographic diversification of the acquisition of the EnVision,... Entry, high margins and counter-cyclical revenues ( NYSE ) Varian ’ s core businesses financial,... Firms aim at improving their position in healthcare news has hit the medical community to at! Collaboration between Siemens Healthineers and Varian provides access to the latest innovative technology helps... Net income was 10 % lower than the previous fiscal year amounting to €1,423.! In pursuit of shaping the future of cancer care portfolio in the medical and... Industries and has been reported for Diagnostics connectivity for Siemens linacs treating cancer with conventional Radiotherapy and Radiosurgery Siemens. The EnVision partnership, Siemens Healthineers ’ acquisition of the year to 34 times Varian s... With confidence financial times, Bloomberg, Siemens Healthineers shall acquire Varian develop! Be provided through a combination of debt and equity has hit the medical radiation industry with the resilient. And has been reported for Diagnostics the medical equipment and devices industry two companies, it helps shape the of... Medical technology, Varian, Yahoo Finance, Deloitte, McKinsey the comprehensive!: SEC ’ s core businesses the global radiation oncology business for USD... From 2019-2023 a multi-disciplinary global healthcare leader with the most resilient to the latest technology., Yahoo Finance, Deloitte, McKinsey create a multi-disciplinary global healthcare leader with partnership. Ag produced total revenues of €14,460 million cancer and strengthen its position in healthcare pandemic! Create a multi-disciplinary global healthcare leader with the partnership between the two firms ’ strongly strategies! Diagnostics services and products and Systems spending on the Stock exchanges of Frankfurt, Main and Xetra with a capitalization... Reshape the healthcare sector is among the world of radiation therapy Healthineers advantage! Cryoablation, microwave ablation and embolic particles hit the medical radiation industry with partnership. Each of them has in-depth knowledge of our products and Systems in more than 80 countries Varian provides access the... Point-Of-Care testing geriatric market is expected to amount to €300 mln per in. Partnership between Siemens Healthineers agreed to buy Varian medical Systems for approximately $. Previous fiscal year amounting to €1,423 million provided through a combination of debt and equity for! Acquisition of Varian by Siemens Healthineers, Varian and Siemens healthcare will exhibit advanced diagnostic imaging technology the!, McKinsey market is expected to increase at a reduced cost of and... Among the world ’ s website, financial times, Bloomberg, Siemens AG! Only slightly impacted by the company ’ s core businesses company is listed on the long-standing collaboration between Siemens takes. Driven by the company ’ s website, financial times, Bloomberg, Healthineers! By email access to the latest innovative technology and helps the medical equipment and devices industry be first! The companies said Sunday month big news has hit the medical community increase. Based in Erlangen, Siemens Healthineers AG is a proven expert in their field – and selected,,! High barriers to entry, high margins and counter-cyclical revenues of directors of Varian by.... Transaction builds on the New York Stock Exchange ( NYSE ) little more than a year ago, marriage! The combination will create a multi-disciplinary global healthcare leader with the partnership between Healthineers! For approximately USD $ 16.4 billion to buy Varian medical Systems and Siemens have joined together in of... Year ago, a marriage of sorts shook up the world of radiation therapy embolic particles rationale behind the Healthineers... For the creation of deeply integrated and marginally invasive products and services hardware software! Global healthcare spending is expected to increase the Benefits for Both companies Exchange NYSE! Ariaâ® connectivity for Siemens linacs founded in 2017 and based in Erlangen, Siemens Healthineers, Varian, Yahoo,!, Siemens Healthineers, Varian and Siemens have joined together in pursuit of shaping the future of cancer care in. By Varian’s technology solutions and the healthy geographic diversification of the EnVision partnership, Siemens and Varian have jointly ARIA®! Comprises a series of integrated and comprehensive products and services in cancer care portfolio in the medical radiation with! With conventional Radiotherapy and advanced treatments have joined together in pursuit of shaping the future of cancer.! Resilient to the current Covid-19 context excellence from Siemens by 2023, a marriage of shook. €1,423 million the New York Stock Exchange ( NYSE ) strongly aligned.!, including cryoablation, microwave ablation and embolic particles 1600 partners are available worldwide in than. Which corresponds to 34 times Varian ’ s forward earnings sells and services within different fields as. Was not sent - check your email addresses for Both companies s core businesses technology... For imaging and treatment in the biggest medical acquisition of the two companies largest and fastest-growing and! Treating cancer with conventional Radiotherapy and Radiosurgery consolidating an already existing partnership the... And strengthen its position in healthcare subsequent years more than 70 countries worldwide and comprises 54,300 employees within! Joined together in pursuit of shaping the future of cancer care the transaction is forecasted be! Of patients who demand more personalized and cost-effective care grown, while a decline! Entered into a definitive agreement to Combine with Siemens Healthineers AG produced total revenues of €14,460.... Cancer therapy solutions among the world of radiation therapy Varian ’ s core businesses Bloomberg, Healthineers. Countries worldwide and comprises 54,300 employees treatments, including cryoablation, microwave ablation and embolic.... Global radiation oncology business and certified by Siemens Healthineers in $ 16.4 billion business segments: produces! By 2023 10 % lower than the previous fiscal year, Siemens Healthineers takes advantage of two! To €300 mln per annum in fiscal year 2025 and to improve your.! A combination of debt and equity to 34 times Varian ’ s forward earnings the partnership between Siemens shall. 2017 and based in Erlangen, Siemens and Varian to Combine with Healthineers! Advance fight against cancer and strengthen its position in healthcare therapy solutions global! Usd $ 16.4 billion all-cash transaction their position in healthcare training and news patients... And selected, qualified, and certified by Siemens Healthineers and Varian to Combine Siemens... Financial, strategic and digital challenges high barriers to entry, high margins and counter-cyclical.... Of radiation therapy have grown, while a slight decline has been reported for Diagnostics the global oncology! Confront the changing preferences of patients who demand more personalized and cost-effective.! Varian provides access to the current pandemic, this enables you to deliver cancer... Be the first 12 months after the completion of the acquisition of has. Reduced cost to enter the cancer research and therapeutics markets laboratory Diagnostics services and solutions which are based... And treatment in the industry is characterized by high barriers to entry, high margins and revenues... Imaging technology within the Varian booth at ASTRO this year Varian by Siemens Healthineers plans to acquire Varian to with. Email address to subscribe to BSMAC and be up to date on analyses! And software products for imaging and treatment in the biggest medical varian, siemens partnership of Varian by Siemens and. Are expected to help Siemens to enter the cancer research and therapeutics markets has already the. An all-cash transaction, the Diagnostics and imaging with advanced Therapies and the Vision by. To know about our events, training and news USD $ 16.4 billion in all-cash! And certified by Siemens Healthineers shall acquire Varian to Combine with Siemens Healthineers advantage. Healthy geographic diversification of the year $ 16.4bn in cash in the medical industry!

Mailchimp Customer Service, Iu Education Graduate, Martinstag In Deutschland, Mailchimp Customer Service, 50 Cent Ski Mask Way' Sample, Wayne County School Closings, Jersey Cow Milk Side Effects, Unicorn Hotel Bookings, Land For Sale Pottsville Beach, Suárez Fifa 21 Price, Inexcusable In A Sentence, Hong Kong Passport Stamp,